CELU · Celularity Inc

$0.88 +0.08 (+9.94%) At close · Aug 26

Market Cap

$23.18M

28.95M

Press releases and events scraped from the company's investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

Past events

Date	Event	Type
2025-02-21	A Fully Integrated Cellular and Regenerative Medicine Company – Celularity Investor Presentation February 2025	Presentation
2024-09-09	HC Wainwright Conference Presentation, September 9, 2024	Conference
2024-05-31	Abstract 2554: Placental Circulating T Cells Expressing CD16 Demonstrate Potent Efficacy Against Multiple Hematological and Solid Tumor Cancers Through Combination with Various Monoclonal Antibodies	Event
2024-05-21	Celularity Research & Development Day Presentation – May 2024	Presentation
2024-04-10	AACR 2024 Abstract #5232 – Placental Circulating T Cells Expressing CD16 in Combination with Trastuzumab Demonstrate Robust Anti-tumor Antibody-dependent Cellular Cytotoxicity (ADCC) Against Gastric Cancer	Event
2022-09-30	Jefferies Cell and Genetic Medicine Summit	Webcast
2022-09-14	Celularity at Morgan Stanley 20th Annual Global Healthcare Conference	Conference
2022-09-12	Celularity at H.C. Wainwright 24th Annual Global Investment Conference	Conference
2022-03-17	Celularity at Oppenheimer 32nd Annual Healthcare Conference	Conference

Source: https://www.celularity.com/investor-relations

Key facts CIK 1752828 CUSIP 151190204 13F (30d) 35 filings 35 filers Visit website Investor relations